US Stock MarketDetailed Quotes

Enanta Pharmaceuticals (ENTA)

Watchlist
  • 14.030
  • -0.500-3.44%
Close May 13 16:00 ET
407.97MMarket Cap-5.40P/E (TTM)

Enanta Pharmaceuticals (ENTA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2026
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
46.95%-7.16M
30.37%-11.7M
75.53%-19.27M
37.61%-6.49M
218.48%17.51M
52.84%-13.49M
32.76%-16.8M
23.64%-78.76M
51.86%-10.4M
54.01%-14.78M
Net income from continuing operations
42.19%-13.09M
46.44%-11.94M
29.43%-81.89M
35.12%-18.7M
19.43%-18.26M
27.32%-22.64M
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
Operating gains losses
----
----
-62.50%6K
--0
--0
--0
--6K
-89.33%16K
----
----
Depreciation and amortization
0.50%1.21M
38.36%1.23M
96.32%4.59M
168.06%1.28M
103.70%1.21M
93.72%1.2M
38.47%889K
-1.48%2.34M
-28.40%479K
-8.76%594K
Other non cash items
113.86%725K
-6.71%-1.94M
-144.44%-952K
9.74%2.47M
-230.10%-1.94M
211.51%339K
-331.17%-1.82M
140.85%2.14M
131.37%2.25M
-129.91%-588K
Change In working capital
-102.32%-49K
-2,650.44%-2.88M
459.73%39.91M
-41.25%5.38M
1,098.59%32.3M
163.04%2.11M
108.18%113K
-11.14%7.13M
47.62%9.16M
318.93%2.7M
-Change in receivables
242.70%665K
-6.20%-1.61M
3,164.44%31.76M
-25.73%1.48M
3,923.58%32.27M
-488.33%-466K
-424.91%-1.52M
-89.67%973K
-61.74%1.99M
-147.95%-844K
-Change in prepaid assets
-235.08%-2.47M
145.69%4.25M
349.76%3.82M
-42.04%1.65M
68.05%-1.38M
-21.01%1.83M
9,505.56%1.73M
367.03%850K
-25.24%2.85M
-67.30%-4.33M
-Change in payables and accrued expense
260.18%1.76M
-70.21%-5.24M
79.32%-1.25M
249.08%1.7M
-51.29%1.23M
81.31%-1.1M
-97.06%-3.08M
-63.39%-6.06M
62.61%-1.14M
536.10%2.53M
-Change in other current assets
-49.64%567K
-64.31%546K
-36.66%4.31M
-68.71%703K
-33.26%951K
-33.10%1.13M
5.52%1.53M
51.53%6.81M
72.32%2.25M
9.95%1.43M
-Change in other current liabilities
-172.08%-524K
-156.94%-825K
-72.25%1.27M
-103.55%-139K
-123.95%-771K
147.24%727K
239.73%1.45M
293.47%4.56M
429.88%3.92M
426.14%3.22M
-Change in other working capital
---51K
---1K
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
46.95%-7.16M
30.37%-11.7M
75.53%-19.27M
37.61%-6.49M
218.48%17.51M
52.84%-13.49M
32.76%-16.8M
23.64%-78.76M
51.86%-10.4M
54.01%-14.78M
Investing cash flow
Cash flow from continuing investing activities
373.33%11.94M
-168.64%-47.3M
-30.72%40.35M
-87.96%2.3M
-317.38%-26.48M
-107.45%-4.37M
625.30%68.9M
208.69%58.24M
61.14%19.07M
95.65%-6.35M
Net PPE purchase and sale
99.41%-15K
98.36%-143K
28.15%-12.9M
83.71%-1.46M
97.63%-155K
-52.16%-2.54M
-1,011.18%-8.75M
-98.15%-17.95M
-554.31%-8.95M
-204.14%-6.54M
Net investment purchase and sale
753.03%11.96M
-160.73%-47.16M
-30.11%53.24M
-86.60%3.75M
-13,464.47%-26.33M
-103.04%-1.83M
729.75%77.65M
271.12%76.18M
112.24%28.02M
100.14%197K
Cash from discontinued investing activities
Investing cash flow
373.33%11.94M
-168.64%-47.3M
-30.72%40.35M
-87.96%2.3M
-317.38%-26.48M
-107.45%-4.37M
625.30%68.9M
208.69%58.24M
61.14%19.07M
95.65%-6.35M
Financing cash flow
Cash flow from continuing financing activities
-5.92%-7.3M
1,386.32%64.14M
3.65%-26.62M
-15.33%-8.32M
3.35%-6.42M
-7.37%-6.89M
32.16%-4.99M
-113.94%-27.63M
-31,269.57%-7.22M
-103.33%-6.65M
Net issuance payments of debt
----
-18.47%-5.86M
----
----
----
----
31.03%-4.94M
---27.48M
---7.26M
----
Net common stock issuance
--0
--69.95M
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
--49K
50.00%141K
-1.36%145K
-25.00%51K
--0
--0
--94K
-93.34%147K
--68K
-86.00%28K
Net other financing activities
-11.58%-13.2M
29.20%-97K
3.64%-26.76M
3.64%-26.5M
-13.59%11.7M
13.22%-11.83M
25.14%-137K
-114.18%-27.77M
-119,456.52%-27.5M
-93.22%13.54M
Cash from discontinued financing activities
Financing cash flow
-5.92%-7.3M
1,386.32%64.14M
3.65%-26.62M
-15.33%-8.32M
3.35%-6.42M
-7.37%-6.89M
32.16%-4.99M
-113.94%-27.63M
-31,269.57%-7.22M
-103.33%-6.65M
Net cash flow
Beginning cash position
-53.81%40.8M
-13.45%35.66M
-53.89%41.2M
21.21%48.17M
-5.83%63.57M
101.17%88.32M
-53.89%41.2M
86.31%89.36M
-59.91%39.74M
-12.49%67.51M
Current changes in cash
89.86%-2.51M
-89.09%5.14M
88.49%-5.54M
-958.30%-12.51M
44.53%-15.4M
-204.81%-24.74M
203.65%47.12M
-216.33%-48.16M
114.89%1.46M
-226.22%-27.77M
End cash Position
-39.77%38.29M
-53.81%40.8M
-13.45%35.66M
-13.45%35.66M
21.21%48.17M
-5.83%63.57M
101.17%88.32M
-53.89%41.2M
-53.89%41.2M
-59.91%39.74M
Free cash flow
55.25%-7.17M
53.64%-11.84M
66.74%-32.17M
58.93%-7.95M
181.40%17.35M
47.05%-16.03M
0.89%-25.55M
13.81%-96.71M
15.76%-19.35M
37.81%-21.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Mar 31, 2026(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 46.95%-7.16M30.37%-11.7M75.53%-19.27M37.61%-6.49M218.48%17.51M52.84%-13.49M32.76%-16.8M23.64%-78.76M51.86%-10.4M54.01%-14.78M
Net income from continuing operations 42.19%-13.09M46.44%-11.94M29.43%-81.89M35.12%-18.7M19.43%-18.26M27.32%-22.64M33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M
Operating gains losses ---------62.50%6K--0--0--0--6K-89.33%16K--------
Depreciation and amortization 0.50%1.21M38.36%1.23M96.32%4.59M168.06%1.28M103.70%1.21M93.72%1.2M38.47%889K-1.48%2.34M-28.40%479K-8.76%594K
Other non cash items 113.86%725K-6.71%-1.94M-144.44%-952K9.74%2.47M-230.10%-1.94M211.51%339K-331.17%-1.82M140.85%2.14M131.37%2.25M-129.91%-588K
Change In working capital -102.32%-49K-2,650.44%-2.88M459.73%39.91M-41.25%5.38M1,098.59%32.3M163.04%2.11M108.18%113K-11.14%7.13M47.62%9.16M318.93%2.7M
-Change in receivables 242.70%665K-6.20%-1.61M3,164.44%31.76M-25.73%1.48M3,923.58%32.27M-488.33%-466K-424.91%-1.52M-89.67%973K-61.74%1.99M-147.95%-844K
-Change in prepaid assets -235.08%-2.47M145.69%4.25M349.76%3.82M-42.04%1.65M68.05%-1.38M-21.01%1.83M9,505.56%1.73M367.03%850K-25.24%2.85M-67.30%-4.33M
-Change in payables and accrued expense 260.18%1.76M-70.21%-5.24M79.32%-1.25M249.08%1.7M-51.29%1.23M81.31%-1.1M-97.06%-3.08M-63.39%-6.06M62.61%-1.14M536.10%2.53M
-Change in other current assets -49.64%567K-64.31%546K-36.66%4.31M-68.71%703K-33.26%951K-33.10%1.13M5.52%1.53M51.53%6.81M72.32%2.25M9.95%1.43M
-Change in other current liabilities -172.08%-524K-156.94%-825K-72.25%1.27M-103.55%-139K-123.95%-771K147.24%727K239.73%1.45M293.47%4.56M429.88%3.92M426.14%3.22M
-Change in other working capital ---51K---1K--------------------------------
Cash from discontinued investing activities
Operating cash flow 46.95%-7.16M30.37%-11.7M75.53%-19.27M37.61%-6.49M218.48%17.51M52.84%-13.49M32.76%-16.8M23.64%-78.76M51.86%-10.4M54.01%-14.78M
Investing cash flow
Cash flow from continuing investing activities 373.33%11.94M-168.64%-47.3M-30.72%40.35M-87.96%2.3M-317.38%-26.48M-107.45%-4.37M625.30%68.9M208.69%58.24M61.14%19.07M95.65%-6.35M
Net PPE purchase and sale 99.41%-15K98.36%-143K28.15%-12.9M83.71%-1.46M97.63%-155K-52.16%-2.54M-1,011.18%-8.75M-98.15%-17.95M-554.31%-8.95M-204.14%-6.54M
Net investment purchase and sale 753.03%11.96M-160.73%-47.16M-30.11%53.24M-86.60%3.75M-13,464.47%-26.33M-103.04%-1.83M729.75%77.65M271.12%76.18M112.24%28.02M100.14%197K
Cash from discontinued investing activities
Investing cash flow 373.33%11.94M-168.64%-47.3M-30.72%40.35M-87.96%2.3M-317.38%-26.48M-107.45%-4.37M625.30%68.9M208.69%58.24M61.14%19.07M95.65%-6.35M
Financing cash flow
Cash flow from continuing financing activities -5.92%-7.3M1,386.32%64.14M3.65%-26.62M-15.33%-8.32M3.35%-6.42M-7.37%-6.89M32.16%-4.99M-113.94%-27.63M-31,269.57%-7.22M-103.33%-6.65M
Net issuance payments of debt -----18.47%-5.86M----------------31.03%-4.94M---27.48M---7.26M----
Net common stock issuance --0--69.95M--------------0--0------------
Proceeds from stock option exercised by employees --49K50.00%141K-1.36%145K-25.00%51K--0--0--94K-93.34%147K--68K-86.00%28K
Net other financing activities -11.58%-13.2M29.20%-97K3.64%-26.76M3.64%-26.5M-13.59%11.7M13.22%-11.83M25.14%-137K-114.18%-27.77M-119,456.52%-27.5M-93.22%13.54M
Cash from discontinued financing activities
Financing cash flow -5.92%-7.3M1,386.32%64.14M3.65%-26.62M-15.33%-8.32M3.35%-6.42M-7.37%-6.89M32.16%-4.99M-113.94%-27.63M-31,269.57%-7.22M-103.33%-6.65M
Net cash flow
Beginning cash position -53.81%40.8M-13.45%35.66M-53.89%41.2M21.21%48.17M-5.83%63.57M101.17%88.32M-53.89%41.2M86.31%89.36M-59.91%39.74M-12.49%67.51M
Current changes in cash 89.86%-2.51M-89.09%5.14M88.49%-5.54M-958.30%-12.51M44.53%-15.4M-204.81%-24.74M203.65%47.12M-216.33%-48.16M114.89%1.46M-226.22%-27.77M
End cash Position -39.77%38.29M-53.81%40.8M-13.45%35.66M-13.45%35.66M21.21%48.17M-5.83%63.57M101.17%88.32M-53.89%41.2M-53.89%41.2M-59.91%39.74M
Free cash flow 55.25%-7.17M53.64%-11.84M66.74%-32.17M58.93%-7.95M181.40%17.35M47.05%-16.03M0.89%-25.55M13.81%-96.71M15.76%-19.35M37.81%-21.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More